Thanksgiving is around the corner and this week delivered a bounty of deals that have a number of life science companies expressing their thanks a little early.
One deal saw a company land a whopping $800 million upfront for a rights... Read more »
The wait is finally over.
Amazon said Tuesday it plans to significantly expand its presence in the New York City and Washington, DC, metropolitan areas beginning next year. The announcement was widely expected following news reports identifying the locales as likely... Read more »
GreatCall, the maker of the Jitterbug cellphone and other products and services for older adults, has extended its partnership with the San Francisco-based ride-hailing company Lyft to offer GreatCall customers the ability to schedule rides without a smartphone app. No financial... Read more »
Nuance Communications is selling its document imaging division to Kofax for $400 million in cash, as Nuance’s new CEO narrows the company’s focus on its conversational artificial intelligence products and cloud-related technologies.
It’s hard to say no to $8 billion. Qualtrics, the enterprise software firm that was on the verge of going public, has pulled its IPO in favor of selling to German software giant SAP for $8 billion in cash.
Qualtrics—which has... Read more »
Treatments for patients who have atrial fibrillation (AF), an irregular heartbeat, include pills that take time to work, or hospital-based procedures. InCarda Therapeutics aims to offer an alternative: a fast-acting inhalable drug that patients would take at home. The startup is... Read more »
Serial entrepreneur Mike Grey is launching a biotech enterprise with $120 million in new funding to advance two investigational liver disease drugs—one of which he has worked to develop before.
Called Mirum Pharmaceuticals, the startup is developing a compound, maralixibat, to... Read more »
Dallas — A foundation started by a Texas billionaire announced Tuesday it will offer millions of dollars in awards to scientists who research neurodegenerative diseases such as Alzheimer’s and progressive supranuclear palsy.
The Rainwater Charitable Foundation, which was founded in the... Read more »
Mitek Systems, which is being targeted for takeover by a subsidiary of Elliott, billionaire Paul Singer’s activist hedge fund, has unanimously rejected its $380 million offer.
Broadcom is selling application security testing business Veracode for $950 million to private equity firm Thoma Bravo. Broadcom gained Veracode as a part of its blockbuster acquisition of CA Technologies.
The second-most advanced investigational drug in MEI Pharma’s four-asset portfolio is drawing attention from overseas as a potential treatment for several leukemias and lymphomas.
Japanese life sciences company Kyowa Hakko Kirin has agreed to pay the San Diego company $10 million... Read more »
The gene-editing technology CRISPR-Cas9 is opening up new research avenues all the time, such as giving drug developers a cheaper, faster way to knock out genes in tumor cells.
Studies of CRISPR-Cas9 to treat human disease are about to start,... Read more »
In some ways, the biggest software acquisition of all time could be a yawner.
IBM’s planned $34 billion deal to acquire open-source software maker Red Hat is a hefty price to pay to give its cloud computing business a shot in... Read more »
Director, Stanford University Artificial Intelligence Laboratory
Chairman and CEO, X PRIZE Foundation
Chair, Dept. of Cellular and Molecular Pharmacology, UCSF
Director, Neurobiotics Laboratory, University of Washington
Partner, Morgenthaler Ventures
President and CEO, On Demand Therapeutics
Director, Energy Biosciences Inst., UC Berkeley
Partner, Kleiner Perkins Caufield & Byers
W20 chairman and CEO
Managing Director, GE; Former Managing Partner, Venture Valkyrie
Vice Chairman for Innovation of SRI International